click below
click below
Normal Size Small Size show me how
Pharm Parkinson's
Question | Answer |
---|---|
Levodopa MOA | increase dopamine in brain then stimulates dopaminergic receptors in basal ganglia to improve balance between dopaminergic & cholinergic activity |
Levodopa/Carbodopa MOA | levodopa plus inhibits peripheral breakdown of levodopa by inhibiting its decarboxylation thereby increasing available levodopa @ bbb |
Symmetrol MOA | antiviral against influenza A, blocks reuptake of dopamine into presynaptic neurons & causing direct stimulation of post synaptic receptors |
Selegline MOA | potent MAO-B inhibitor (metabolizes dopamine & increases dopaminergic activity by interfering w/ dopamine reuptake @ synapse |
COMT Inhibitors MOA | reversibly & selectively inhibits COMT |
Comtan MOA | inc duration of levodopa by 42-65%, only acts peripherally, no lab monitoring (COMT inhibitor) |
Tasmar MOA | more potent & longer acting, increases duration of dopamine by 94%, acts peripherally & centrally, need baseline & periodic LFTs (COMT inhibitor) |
Parlodel MOA | semisynthetic ergot alkaloid derivative w/ dopaminergic properties, inhibits PRL secretion, direct stimulation of dopamine receptors in corpus stratum (dopamine agonist) |
Permax MOA | semisynthetic ergot similar to parlodel but more potent & longer acting, centrally active dopamine agonist stimulating D1 & D2 receptors (dopamine agonist) |
Mirapex MOA | nonergot dopamine agonist w/ specificity for D2 receptor & binds to D3 and D4 which stimulates dopamine activity on nerves on striatum & substantia nigra |
Requip MOA | unknown, stimulant of postsynaptic dopamine D2 w/in caudate |